ITC To Investigate Roche At Amgen's Behest
In a move signifying a boon for Amgen Inc. and a threat to the proposed sales of Hoffman-La Roche Inc.'s anti-anemia drug C.E.R.A. in the U.S., the U.S. International Trade Commission...To view the full article, register now.
Already a subscriber? Click here to view full article